Abstract

Mini Review

Heart failure with preserved ejection fraction: A mini review

Nathan Buila and Jean-René M’Buyamba-Kabangu*

Published: 22 July, 2022 | Volume 6 - Issue 1 | Pages: 005-006

Over the past 20 years, there has been a surge of clinical investigations and useful trials on heart failure (HF) with preserved ejection fraction (HFpEF). HFpEF represents the largest phenotype of HF, a public health concern for its link with high mortality and rates of morbidity.

Read Full Article HTML DOI: 10.29328/journal.avm.1001016 Cite this Article Read Full Article PDF

References

  1. Shah SJ, Kitzman DW, Borlaug BA, van Heerebeek L, Zile MR, Kass DA, Paulus WJ. Phenotype-Specific Treatment of Heart Failure With Preserved Ejection Fraction: A Multiorgan Roadmap. Circulation. 2016 Jul 5;134(1):73-90. doi: 10.1161/CIRCULATIONAHA.116.021884. PMID: 27358439; PMCID: PMC4930115.
  2. Li P, Zhao H, Zhang J, Ning Y, Tu Y, Xu D, Zeng Q. Similarities and Differences Between HFmrEF and HFpEF. Front Cardiovasc Med. 2021 Sep 20;8:678614. doi: 10.3389/fcvm.2021.678614. PMID: 34616777; PMCID: PMC8488158.
  3. Seravalle G, Quarti-Trevano F, Dell'Oro R, Gronda E, Spaziani D, Facchetti R, Cuspidi C, Mancia G, Grassi G. Sympathetic and baroreflex alterations in congestive heart failure with preserved, midrange and reduced ejection fraction. J Hypertens. 2019 Feb;37(2):443-448. doi: 10.1097/HJH.0000000000001856. PMID: 30020242.
  4. Pfeffer MA, Shah AM, Borlaug BA. Heart Failure With Preserved Ejection Fraction In Perspective. Circ Res. 2019 May 24;124(11):1598-1617. doi: 10.1161/CIRCRESAHA.119.313572. PMID: 31120821; PMCID: PMC6534165.
  5. Anker SD, Butler J, Filippatos G, Ferreira JP, Bocchi E, Böhm M, Brunner-La Rocca HP, Choi DJ, Chopra V, Chuquiure-Valenzuela E, Giannetti N, Gomez-Mesa JE, Janssens S, Januzzi JL, Gonzalez-Juanatey JR, Merkely B, Nicholls SJ, Perrone SV, Piña IL, Ponikowski P, Senni M, Sim D, Spinar J, Squire I, Taddei S, Tsutsui H, Verma S, Vinereanu D, Zhang J, Carson P, Lam CSP, Marx N, Zeller C, Sattar N, Jamal W, Schnaidt S, Schnee JM, Brueckmann M, Pocock SJ, Zannad F, Packer M; EMPEROR-Preserved Trial Investigators. Empagliflozin in Heart Failure with a Preserved Ejection Fraction. N Engl J Med. 2021 Oct 14;385(16):1451-1461. doi: 10.1056/NEJMoa2107038. Epub 2021 Aug 27. PMID: 34449189.
  6. Ariyaratnam JP, Elliott AD, Mishima RS, Gallagher C, Lau DH, Sanders P. Heart failure with preserved ejection fraction: An alternative paradigm to explain the clinical implications of atrial fibrillation. Heart Rhythm O2. 2021 Dec 17;2(6Part B):771-783. doi: 10.1016/j.hroo.2021.09.015. PMID: 34988529; PMCID: PMC8710629.
  7. Heidenreich PA, Bozkurt B, Aguilar D, Allen LA, Byun JJ, Colvin MM, Deswal A, Drazner MH, Dunlay SM, Evers LR, Fang JC, Fedson SE, Fonarow GC, Hayek SS, Hernandez AF, Khazanie P, Kittleson MM, Lee CS, Link MS, Milano CA, Nnacheta LC, Sandhu AT, Stevenson LW, Vardeny O, Vest AR, Yancy CW. 2022 AHA/ACC/HFSA Guideline for the Management of Heart Failure: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines. Circulation. 2022 May 3;145(18):e895-e1032. doi: 10.1161/CIR.0000000000001063. Epub 2022 Apr 1. Erratum in: Circulation. 2022 May 3;145(18):e1033. PMID: 35363499.
  8. Maryniak A, Maisuradze N, Ahmed R, Biskupski P, Jayaraj J, Budzikowski AS. Heart failure with preserved ejection fraction update: A review of clinical trials and new therapeutic considerations. Cardiol J. 2022;29(4):670-679. doi: 10.5603/CJ.a2022.0051. Epub 2022 Jun 28. PMID: 35762077; PMCID: PMC9273251.
  9. Miyagi C, Fukamachi K, Kuban BD, Gao S, Miyamoto T, Flick CR, Polakowski AR, Horvath DJ, Starling RC, Karimov JH. Left Atrial Circulatory Assistance in Simulated Diastolic Heart Failure Model: First in Vitro and in Vivo. J Card Fail. 2022 May;28(5):789-798. doi: 10.1016/j.cardfail.2021.11.024. Epub 2022 Jan 10. PMID: 35027316; PMCID: PMC9106897.

Figures:

Similar Articles

Recently Viewed

Read More

Most Viewed

Read More

Help ?